Applicant, as named in the Orange Book

Abbvie

Next listed expiry: Lumigan on 13 Jun 2027. 27 products with live protection, 33 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Lumigan bimatoprost	bimatoprost	022184	13 Jun 2027	patent
Acular Ls ketorolac tromethamine	ketorolac tromethamine	021528	24 Nov 2027	patent
Lastacaft alcaftadine	alcaftadine	022134	23 Dec 2027	patent, carve-out possible
Dalvance dalbavancin hydrochloride	dalbavancin hydrochloride	021883	23 May 2028	patent, carve-out possible
Canasa mesalamine	mesalamine	021252	6 Jun 2028	patent
Acuvail ketorolac tromethamine	ketorolac tromethamine	022427	15 Aug 2029	patent
Savella · 4 strengths milnacipran hydrochloride	milnacipran hydrochloride	022256	19 Sep 2029	patent, carve-out possible
Namzaric · 4 strengths donepezil hydrochloride; memantine hydrochloride	donepezil hydrochloride; memantine hydrochloride	206439	5 Dec 2029	patent, carve-out possible
Vraylar · 6 strengths cariprazine hydrochloride	cariprazine hydrochloride	204370	17 Mar 2030	patent
Teflaro · 2 strengths ceftaroline fosamil	ceftaroline fosamil	200327	10 Feb 2031	patent
Kybella deoxycholic acid	deoxycholic acid	206333	17 Feb 2032	patent, carve-out possible
Fetzima · 4 strengths levomilnacipran hydrochloride	levomilnacipran hydrochloride	204168	23 May 2032	patent
Avycaz avibactam sodium; ceftazidime	avibactam sodium; ceftazidime	206494	15 Jun 2032	patent
Emblaveo avibactam sodium; aztreonam	avibactam sodium; aztreonam	217906	7 Feb 2033	exclusivity
Viberzi · 2 strengths eluxadoline	eluxadoline	206940	14 Mar 2033	patent
Venclexta · 3 strengths venetoclax	venetoclax	208573	6 Sep 2033	patent, carve-out possible
Linzess · 3 strengths linaclotide	linaclotide	202811	16 Feb 2034	patent
Durysta bimatoprost	bimatoprost	211911	31 Oct 2034	patent
Mavyret glecaprevir; pibrentasvir	glecaprevir; pibrentasvir	215110	5 Dec 2035	patent
Rinvoq Lq upadacitinib	upadacitinib	218347	17 Oct 2036	patent
Mavyret glecaprevir; pibrentasvir	glecaprevir; pibrentasvir	209394	24 Dec 2036	patent
Rinvoq · 3 strengths upadacitinib	upadacitinib	211675	9 Mar 2038	patent, carve-out possible
Vyalev foscarbidopa; foslevodopa	foscarbidopa; foslevodopa	216962	10 Jun 2040	patent, carve-out possible
Oriahnn (Copackaged) elagolix sodium,estradiol,norethindrone acetate; elagolix sodium	elagolix sodium,estradiol,norethindrone acetate; elagolix sodium	213388	27 Aug 2040	patent, carve-out possible
Orilissa · 2 strengths elagolix sodium	elagolix sodium	210450	27 Aug 2040	patent, carve-out possible
Qulipta · 3 strengths atogepant	atogepant	215206	29 Jul 2041	patent, carve-out possible
Ubrelvy · 2 strengths ubrogepant	ubrogepant	211765	22 Dec 2041	patent, carve-out possible

Recent events

26 Oct 2026Asacol Hd · Generic approved 13 Oct 2026
25 Oct 2026Tricor · Generic approved 21 Jan 2026
25 Oct 2026Venclexta · First generic approved 15 May 2026
25 Oct 2026Venclexta · Generic approved 15 May 2026
25 Oct 2026Pred Forte · Generic approved 28 Sep 2026
25 Oct 2026Viberzi · Generic approved 2 Jun 2026
25 Oct 2026Kaletra · Generic approved 11 Dec 2025
25 Oct 2026Dalvance · First generic approved 23 Oct 2025
25 Oct 2026Dalvance · Generic approved 23 Oct 2025
25 Oct 2026Dalvance · Generic approved 26 Nov 2025
25 Oct 2026Dalvance · Generic approved 10 Nov 2025
25 Oct 2026Carafate · Generic approved 14 Oct 2026
25 Oct 2026Savella · Generic approved 15 Sep 2026
25 Oct 2026Savella · Generic approved 15 Sep 2026
25 Oct 2026Combigan · Generic approved 1 Jul 2026
25 Oct 2026Fml Forte · Generic approved 12 Feb 2026
25 Oct 2026Namzaric · Generic approved 13 Oct 2026
25 Oct 2026Rectiv · Generic approved 6 Jul 2026
25 Oct 2026Linzess · Generic approved 24 Sep 2026
25 Oct 2026Rectiv · Generic approved 18 Dec 2025
25 Oct 2026Lexapro · Generic approved 22 Apr 2026
25 Oct 2026Ubrelvy · Generic tentatively approved 24 Jun 2026
25 Oct 2026Combigan · Generic approved 11 Jun 2026
25 Oct 2026Ubrelvy · Generic tentatively approved 14 May 2026
25 Oct 2026Dalvance · Generic approved 26 Feb 2026
25 Oct 2026Dalvance · Generic approved 4 Jun 2026
25 Oct 2026Vraylar · Generic approved 16 Dec 2025
25 Oct 2026Lumigan · Generic approved 22 Sep 2025
25 Oct 2026Carafate · Generic approved 5 Jan 2026
24 Oct 2026Mavyret · Exclusivity expires within 90 days PED30 Oct 2026
24 Oct 2026Byvalson · Enters 12-month window basis: patent, carve-out possible4 Oct 2027
24 Oct 2026Lumigan · Enters 12-month window basis: patent13 Jun 2027

Products without listed protection (33)

Drug	Ingredient	NDA	Earliest generic entry	Basis
Acular ketorolac tromethamine	ketorolac tromethamine	019700	open now	no listed protection
Alphagan P brimonidine tartrate	brimonidine tartrate	021262	open now	no listed protection
Alphagan P brimonidine tartrate	brimonidine tartrate	021770	open now	no listed protection
Carafate sucralfate	sucralfate	018333	open now	no listed protection
Celexa · 3 strengths citalopram hydrobromide	citalopram hydrobromide	020822	open now	no listed protection
Combigan brimonidine tartrate; timolol maleate	brimonidine tartrate; timolol maleate	021398	open now	no listed protection
Crinone progesterone	progesterone	020701	open now	no listed protection
Depakote divalproex sodium	divalproex sodium	019680	open now	no listed protection
Depakote · 3 strengths divalproex sodium	divalproex sodium	018723	open now	no listed protection
Depakote Er · 2 strengths divalproex sodium	divalproex sodium	021168	open now	no listed protection
Duopa carbidopa; levodopa	carbidopa; levodopa	203952	open now	no listed protection
Fml fluorometholone	fluorometholone	016851	open now	no listed protection
Fml Forte fluorometholone	fluorometholone	019216	open now	no listed protection
Juvmo · 3 strengths tavapadon	tavapadon	220415	open now	no listed protection
Juvmo (Copackaged) tavapadon	tavapadon	220415	open now	no listed protection
Kaletra lopinavir; ritonavir	lopinavir; ritonavir	021251	open now	no listed protection
Kaletra · 2 strengths lopinavir; ritonavir	lopinavir; ritonavir	021906	open now	no listed protection
Latisse bimatoprost	bimatoprost	022369	open now	no listed protection
Lexapro · 3 strengths escitalopram oxalate	escitalopram oxalate	021323	open now	no listed protection
Norvir ritonavir	ritonavir	209512	open now	no listed protection
Norvir ritonavir	ritonavir	022417	open now	no listed protection
Oxytrol For Women oxybutynin	oxybutynin	202211	open now	no listed protection
Ozurdex dexamethasone	dexamethasone	022315	open now	no listed protection
Pred Forte prednisolone acetate	prednisolone acetate	017011	open now	no listed protection
Pred Mild prednisolone acetate	prednisolone acetate	017100	open now	no listed protection
Restasis cyclosporine	cyclosporine	050790	open now	no listed protection
Restasis Multidose cyclosporine	cyclosporine	050790	open now	no listed protection
Saphris · 3 strengths asenapine maleate	asenapine maleate	022117	open now	no listed protection
Synthroid · 12 strengths levothyroxine sodium	levothyroxine sodium	021402	open now	no listed protection
Ultane sevoflurane	sevoflurane	020478	open now	no listed protection
Viibryd · 3 strengths vilazodone hydrochloride	vilazodone hydrochloride	022567	open now	no listed protection
Zemplar · 3 strengths paricalcitol	paricalcitol	020819	open now	no listed protection
Zymaxid gatifloxacin	gatifloxacin	022548	open now	no listed protection